These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 78844)
1. Closer correlation between serum triiodothyronine and basal metabolic rate during antithyroid drug treatment in patients with Graves' disease. Hamada N; Miura T; Ban Y; Momotani N; Nishikawa Y; Ohno M; Morii H; Kitabatake S; Ito K Endocrinol Jpn; 1978 Apr; 25(2):117-22. PubMed ID: 78844 [TBL] [Abstract][Full Text] [Related]
2. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. Kallner G; Vitols S; Ljunggren JG J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146 [TBL] [Abstract][Full Text] [Related]
3. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484 [TBL] [Abstract][Full Text] [Related]
4. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
5. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. Andrade VA; Gross JL; Maia AL J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642 [TBL] [Abstract][Full Text] [Related]
6. T4 suppression test involving 24-hour thyroidal 131I uptake in patients with Graves' disease compared to the T3 suppression test. Kobayashi I; Ishii H; Mori M; Kobayashi S Endocrinol Jpn; 1984 Jun; 31(3):263-70. PubMed ID: 6548699 [TBL] [Abstract][Full Text] [Related]
7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs]. Takamatsu J Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686 [No Abstract] [Full Text] [Related]
9. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139 [TBL] [Abstract][Full Text] [Related]
10. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. Wenzel KW; Lente JR J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375 [TBL] [Abstract][Full Text] [Related]
11. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092 [TBL] [Abstract][Full Text] [Related]
13. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. Izumi M; Larsen PR Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562 [TBL] [Abstract][Full Text] [Related]
15. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs. Buerklin EM; Schimmel M; Utiger RD J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733 [TBL] [Abstract][Full Text] [Related]
16. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease. Chen JJ; Ladenson PW J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547 [TBL] [Abstract][Full Text] [Related]
17. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177 [TBL] [Abstract][Full Text] [Related]
18. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients. Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435 [TBL] [Abstract][Full Text] [Related]
19. Transient recurrence of hyperthyroidism after delivery in Graves' disease. Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of propylthiouracil and methimazol on circulating thyroid hormones and various measures of peripheral thyroid hormone effects in thyrotoxic patients. Laurberg P; Tørring J; Weeke J Acta Endocrinol (Copenh); 1985 Jan; 108(1):51-4. PubMed ID: 3838216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]